JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4601
Amplify CWP Enhanced Dividend Income ETF
DIVO
$7.77B
| $783K | ﹤0.01% |
19,350
-1,636
| -8% | -$67.9K |
2024 Q2
2 quarters
|
|
4602
iShares Core Moderate Allocation ETF
AOM
$1.87B
| $782K | ﹤0.01% |
18,011
-15,476
| -46% | -$686K |
2021 Q2
14 quarters
|
|
4603
First Trust Large Cap Growth AlphaDEX Fund
FTC
$1.35B
| $778K | ﹤0.01% |
5,627
+165
| +3% | +$23K |
2022 Q4
8 quarters
|
|
4604
Parke Bancorp
PKBK
$387M
| $778K | ﹤0.01% |
37,926
+21,841
| +136% | +$477K |
2021 Q4
12 quarters
|
|
4605
Aura Biosciences
AURA
$632M
| $776K | ﹤0.01% |
94,386
+40,884
| +76% | +$385K |
2021 Q4
12 quarters
|
|
4606
Gencor Industries
GENC
$258M
| $773K | ﹤0.01% |
43,804
+24,093
| +122% | +$498K |
2017 Q4
28 quarters
|
|
|
NXDT
4607
NexPoint Diversified Real Estate Trust
NXDT
$281M
| $772K | ﹤0.01% |
126,495
+59,625
| +89% | +$350K |
2023 Q2
6 quarters
|
|
4608
Alico
ALCO
$284M
| $769K | ﹤0.01% |
29,670
+16,530
| +126% | +$432K |
2022 Q2
10 quarters
|
|
4609
Global X US Preferred ETF
PFFD
$2.05B
| $768K | ﹤0.01% |
39,367
+3,432
| +10% | +$69.9K |
2023 Q3
5 quarters
|
|
4610
Xponential Fitness
XPOF
$198M
| $767K | ﹤0.01% |
57,034
+45,173
| +381% | +$621K |
2021 Q3
13 quarters
|
|
|
DAWN
4611
DELISTED
Day One Biopharmaceuticals
DAWN
| $766K | ﹤0.01% |
60,427
-556
| -0.9% | -$7.74K |
2021 Q2
14 quarters
|
|
4612
ClearShares Piton Intermediate Fixed Income ETF
PIFI
$95.3M
| $765K | ﹤0.01% |
8,314
-5,345
| -39% | -$500K |
2023 Q3
5 quarters
|
|
|
YMAB
4613
DELISTED
Y-mAbs Therapeutics
YMAB
| $765K | ﹤0.01% |
97,660
+67,325
| +222% | +$820K |
2018 Q3
25 quarters
|
|
4614
Goldman Sachs Physical Gold ETF Shares
AAAU
$2.52B
| $763K | ﹤0.01% |
29,435
+27,435
| +1,372% | +$722K |
2024 Q3
1 quarter
|
|
4615
Ramaco Resources Class A
METC
$516M
| $759K | ﹤0.01% |
75,696
+4,874
| +7% | +$54.1K |
2017 Q4
28 quarters
|
|
|
FSP
4616
Franklin Street Properties
FSP
$34.3M
| $757K | ﹤0.01% |
413,898
+182,217
| +79% | +$333K |
2013 Q2
46 quarters
|
|
4617
Global X MLP ETF
MLPA
$2.28B
| $756K | ﹤0.01% |
15,308
-990
| -6% | -$48.6K |
2021 Q1
15 quarters
|
|
4618
PUT
Emerson Electric
EMR
$90.1B
| $756K | ﹤0.01% |
6,100
| – | – |
2021 Q1
15 quarters
|
|
4619
BrightSpring Health Services
BTSG
$11.9B
| $756K | ﹤0.01% |
44,365
-119,253
| -73% | -$2.06M |
2024 Q1
3 quarters
|
|
4620
JPMorgan Diversified Return US Small Cap Equity ETF
JPSE
$572M
| $755K | ﹤0.01% |
16,139
-1,441
| -8% | -$70.3K |
2022 Q3
9 quarters
|
|
4621
Village Super Market
VLGEA
$681M
| $755K | ﹤0.01% |
23,680
+16,531
| +231% | +$516K |
2015 Q2
38 quarters
|
|
4622
Schwab Municipal Bond ETF
SCMB
$3.22B
| $754K | ﹤0.01% |
29,378
-86,932
| -75% | -$2.25M |
2023 Q3
5 quarters
|
|
|
FIVA
4623
Fidelity International Value Factor ETF
FIVA
$614M
| $751K | ﹤0.01% |
31,030
-1,464
| -5% | -$37.1K |
2024 Q1
3 quarters
|
|
|
XHYT
4624
DELISTED
BondBloxx USD High Yield Bond Telecom, Media & Technology Sector ETF
XHYT
| $749K | ﹤0.01% |
21,715
-1,251
| -5% | -$43.7K |
2024 Q2
2 quarters
|
|
4625
GoodRx Holdings
GDRX
$1.12B
| $748K | ﹤0.01% |
160,941
+136,648
| +562% | +$751K |
2020 Q3
17 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.